NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023
David S. Ettinger(Sidney Kimmel Comprehensive Cancer Center), Douglas E. Wood(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Dara L. Aisner(University of Colorado Cancer Center), Wallace Akerley(University of Utah), Jessica R. Bauman(Fox Chase Cancer Center), Ankit Bharat(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Débora S. Bruno(Cleveland Clinic), Joe Y. Chang(The University of Texas MD Anderson Cancer Center), Lucian R. Chirieac(Dana-Farber Brigham Cancer Center), Malcolm M. DeCamp(University of Wisconsin Carbone Cancer Center), Thomas J. Dilling(Moffitt Cancer Center), Jonathan E. Dowell(Southwestern Medical Center), Gregory A. Durm(Indiana University Melvin and Bren Simon Comprehensive Cancer Center), Scott Gettinger(Yale Cancer Center), Travis E. Grotz(WinnMed), Matthew A. Gubens(UCSF Helen Diller Family Comprehensive Cancer Center), Aparna Hegde(University of Colorado Cancer Center), Rudy P. Lackner(Susan Thompson Buffett Foundation), Michael Lanuti(Massachusetts General Hospital), Jules Lin, Billy W. Loo(Cancer Institute (WIA)), Christine M. Lovly(Breast Cancer Research Foundation), Fabien Maldonado(Breast Cancer Research Foundation), Erminia Massarelli(City Of Hope National Medical Center), Daniel Morgensztern(Barnes-Jewish Hospital), Thomas Ng(University of Tennessee Health Science Center), Gregory A. Otterson(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Sandip Pravin Patel(UC San Diego Health System), Tejas Patil(University of Colorado Cancer Center), Patricio M. Polanco(Southwestern Medical Center), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), Jonathan W. Riess(UC Davis Comprehensive Cancer Center), Steven E. Schild(WinnMed), Theresa A. Shapiro(Sidney Kimmel Comprehensive Cancer Center), Aditi P. Singh(University of Pennsylvania), James Stevenson(Cleveland Clinic), Alda L. Tam(The University of Texas MD Anderson Cancer Center), Tawee Tanvetyanon(Moffitt Cancer Center), Jane Yanagawa(University of Colorado Cancer Center), Stephen C. Yang(Sidney Kimmel Comprehensive Cancer Center), Edwin Yau(Roswell Park Comprehensive Cancer Center), Kristina M. Gregory(National Comprehensive Cancer Network), Miranda Hughes(National Comprehensive Cancer Network)
Cited by 477Open Access
Abstract
The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus on neoadjuvant and adjuvant (also known as perioperative) systemic therapy options for eligible patients with resectable NSCLC.
Related Papers
No related papers found
Powered by citation graph analysis